FLUOXETINE AUROBINDO

Main information

  • Trade name:
  • FLUOXETINE AUROBINDO Capsule, hard 20MG
  • Dosage:
  • 20MG
  • Pharmaceutical form:
  • Capsule, hard
  • Administration route:
  • Oral use
  • Units in package:
  • 28 Blister
  • Prescription type:
  • with prescription
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • FLUOXETINE AUROBINDO Capsule, hard 20MG
    Czech Republic
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • FLUOXETINE
  • Product summary:
  • FLUOXETINE AUROBINDO

Other information

Status

  • Source:
  • SUKL - Státní ústav pro kontrolu léčiv
  • Authorization status:
  • R - active MA/authorised medicinal product
  • Authorization number:
  • 30/ 005/15-C
  • Last update:
  • 16-01-2018

16-7-2018

Reconcile (Nexcyon Pharmaceuticals Ltd)

Reconcile (Nexcyon Pharmaceuticals Ltd)

Reconcile (Active substance: Fluoxetine) - Centralised - Renewal - Commission Decision (2018)4770 of Mon, 16 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/V/C/133/R-18

Europe -DG Health and Food Safety